celecoxib has been researched along with Cryptococcosis in 1 studies
Cryptococcosis: Fungal infection caused by genus CRYPTOCOCCUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koselny, K | 1 |
| Green, J | 1 |
| DiDone, L | 1 |
| Halterman, JP | 1 |
| Fothergill, AW | 1 |
| Wiederhold, NP | 1 |
| Patterson, TF | 1 |
| Cushion, MT | 1 |
| Rappelye, C | 1 |
| Wellington, M | 1 |
| Krysan, DJ | 1 |
1 other study available for celecoxib and Cryptococcosis
| Article | Year |
|---|---|
The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of Cryptococcosis.
Topics: Animals; Antifungal Agents; Candida; Caspofungin; Celecoxib; Cryptococcosis; Cryptococcus neoformans | 2016 |